Immo Vita SA
Immo Vita reported revenue of 49,000 € for the 2024 financial year (annual accounts filed with the NBB on 02 Sep 2025).
The score of Immo Vita shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets -17 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immo Vita's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | 49,000 € | ||||
| Net result | −55,745 € | ||||
| Equity | −31,883 € | ||||
| EBITDA | 16,775 € | ||||
| Total assets | 609,667 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 02 Sep 2025
- Year ended 31 Dec 2023filed on 02 Sep 2024
- Year ended 31 Dec 2022filed on 03 Nov 2023
- Year ended 31 Dec 2021filed on 29 Dec 2022
- Year ended 31 Dec 2020filed on 18 Nov 2021
Immo Vita's financial analysis
- Solvency-5.2%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immo Vita
Immo Vita's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0454.372.843
- VAT number
- BE0454372843
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 24 Jan 1995
- Registered office
- 1420 Braine-l'Alleud
- Latest accounts
- 2024 · filed on 02 Sep 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Immo Vita (SA) has been based in Braine-l'Alleud since 1995, active in: wholesale of pharmaceutical and medical goods. For 2024, it reports revenue of 49,000 €, a net loss of 55,745 € and equity of −31,883 €. Its solvency stands at -5.2%, below the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Immo Vita
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Revatis Vet Wholesale of pharmaceutical and medical goods Marche-en-Famenne · balance sheet 614,858 €
- Advanced Instruments (Belgium) Wholesale of pharmaceutical and medical goods Brussels · balance sheet 408,689 €
Frequently asked questions about Immo Vita
What is the revenue of Immo Vita?
According to the 2024 annual accounts filed with the NBB, the revenue of Immo Vita amounts to 49,000 €.
What is the VAT number of Immo Vita?
In Belgium, the VAT number is the company number prefixed with BE: BE0454372843 for Immo Vita, if the company is VAT-registered. Its company number (CBE) is 0454.372.843.
Where is the registered office of Immo Vita?
According to the CBE register, the registered office of Immo Vita is in 1420 Braine-l'Alleud.
What is the equity of Immo Vita?
At the close of the 2024 financial year, the equity of Immo Vita amounts to -31,883 €, a solvency of -5.2% of total assets.
Who manages Immo Vita?
The register lists 2 active mandates at Immo Vita. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immo Vita
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →